scholarly journals Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option

2020 ◽  
Vol 8 (19) ◽  
pp. 1247-1247
Author(s):  
Shanthi Sabarimurugan ◽  
Arun Dharmarajan ◽  
Sudha Warrier ◽  
Maheswari Subramanian ◽  
Rajarajan Swaminathan
Keyword(s):  
Fast Track ◽  
Comprehensive Review ◽  
Treatment And Prevention ◽  
Prevention Option

Uaw Opposes ‘Fast-Track’ Trade-Negotiating Authority: it Would Expand Nafta

1998 ◽  
Vol 8 (1) ◽  
pp. 157-166
Author(s):  
Steve Beckman
Keyword(s):  
House Of Representatives ◽  
Fast Track ◽  
September 11 ◽  
Comprehensive Review

Statement before the Subcommittee on Trade, Committee on Ways and Means, U.S. House of Representatives, on Comprehensive Review of the NAFTA, September 11, 1997.

scholarly journals Nipah Virus (NiV) Infection: Is Nepal Prepared for the Possible Outbreak?

2019 ◽  
Vol 6 (1) ◽  
pp. 69-73
Author(s):  
Dhiraj Shrestha ◽  
Balkrishna Bhattachan
Keyword(s):  
High Risk ◽  
General Population ◽  
Nipah Virus ◽  
Molecular Techniques ◽  
Risk Zone ◽  
Natural Reservoir ◽  
Treatment And Prevention ◽  
Fruit Bat ◽  
The World ◽  
Prevention Option

 After 20 years of the first Nipah Virus (NiV) outbreak in the world, it re-emerged as the outbreak in India. WHO has recognized NiV as a potent epidemic threat to human health. Both animal-to-human and human-to-human transmission of zoonotic NiV has been documented. Fruit bat of Pteropodidae family is the natural reservoir of the virus. Thus, the territorial habitat of these bats is the high risk zone of NiV outbreak. The symptoms are very nonspecific and the pathogenicity of NiV is yet to be fully understood. Diagnosis of NiV infection still relies on molecular techniques. Till date, no drugs or vaccines against NiV has been approved. Some research have presented arrays of the possible treatment and prevention option, but without sure shot implications. So, appropriate precautions are the only currently available prevention option. Nepal is yet to experience a NiV outbreak but that does not undermine the risk posed to the general population. High risk countries including Nepal should be well prepared to tackle the possible outbreak in future.

scholarly journals Feline Neonatal Isoerythrolysis and the Importance of Feline Blood Types

2010 ◽  
Vol 2010 ◽  
pp. 1-8 ◽  
Author(s):  
Ana C. Silvestre-Ferreira ◽  
Josep Pastor
Keyword(s):  
Mortality Rate ◽  
Clinical Features ◽  
Type A ◽  
Type B ◽  
Comprehensive Review ◽  
Blood Types ◽  
Treatment And Prevention

Although feline neonatal isoerythrolysis is rare, associated mortality rate is high. It results from mating of type B blood queens with type A or AB blood toms. A comprehensive review on feline blood types and feline neonatal isoerythrolysis physiopathology, clinical features, diagnosis, treatment, and prevention is covered.

scholarly journals The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations

2021 ◽  
Vol 26 (3) ◽  
pp. 220-239
Author(s):  
Sarah Parsons ◽  
Van L Tran
Keyword(s):  
Sickle Cell Disease ◽  
Severe Acute Respiratory Syndrome ◽  
Pediatric Patients ◽  
Review Article ◽  
Special Populations ◽  
Pharmacologic Treatment ◽  
Immunocompromised Patients ◽  
Cell Disease ◽  
Comprehensive Review ◽  
Treatment And Prevention

With the emergence of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus, the pandemic has resulted in a severe respiratory disease known as COVID-19. Data and literature are limited in the evaluation, treatment, and considerations for pediatric patients including special populations (e.g., neonates, children, immunocompromised patients, and those with sickle cell disease). There exists a need for a comprehensive review of pediatric proven and disproven treatments as therapies continue to emerge. This article evaluates the pharmacologic treatment and prevention therapies used in pediatric patients to date, including emergency use authorizations, as well as rationales for pharmacotherapies not routinely used to treat acute COVID-19 infection. It is important to note this review article is current as of January 25, 2021, given the rapid evolvement of the pandemic.

Sign in / Sign up

Export Citation Format

Share Document